Earnings Presentation - Q4 FY26 and FY26
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Artemis Hospitals reported strong Q4 FY26 and full-year FY26 results with robust growth across all metrics. Consolidated revenue grew 16.4% YoY to INR 279 crore in Q4 and 15.4% to INR 1,081 crore for FY26. EBITDA increased 23.1% YoY to INR 59 crore in Q4, with EBITDA margin expanding 116 bps to 21.3% (FY26: 20.2% vs FY25: 19.7%, a 44 bps improvement). PAT surged 32.1% YoY to INR 30 crore in Q4, with FY26 PAT at INR 104 crore (26.2% growth). IP volumes grew 9.2% YoY and ARPOB improved 7.3% YoY in Q4. The company is expanding capacity with new hospitals in Raipur (300+ beds, May/June 2026), South Delhi (650+ beds, FY2029), and Mauritius (110 beds, FY27), targeting ~2,000 beds by 2028. Plans to raise ~INR 700 crore for growth requirements.
The consistent margin expansion and strong profit growth indicate operational efficiency improvements. The expansion pipeline and capital raise signal confidence in sustained growth, though shareholders should monitor the dilution impact of the proposed INR 700 crore raise.